Literature DB >> 26432176

Controlled but not cured: Structural processes and explanatory models of Chagas disease in tropical Bolivia.

Colin Forsyth1.   

Abstract

Dressler (2001:456) characterizes medical anthropology as divided between two poles: the constructivist, which focuses on the "meaning and significance that events have for people," and the structuralist, which emphasizes socioeconomic processes and relationships. This study synthesizes structuralist and constructivist perspectives by investigating how structural processes impact explanatory models of Chagas disease in a highly endemic area. The research took place from March-June 2013 through the Centro Medico Humberto Parra, a non-profit clinic servicing low income populations in Palacios, Bolivia and surrounding communities. Semistructured interviews (n = 68) and consensus analysis questionnaires (n = 48) were administered to people dealing with Chagas disease. In the interview narratives, respondents link Chagas disease with experiences of marginalization and rural poverty, and describe multilayered impediments to accessing treatment. They often view the disease as incurable, but this reflects inconsistent messages from the biomedical system. The consensus analysis results show strong agreement on knowledge of the vector, ethnomedical treatment, and structural factors related to Chagas disease. In interpreting Chagas disease, respondents account for the structural factors which place them at risk and impede access to care.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bolivia; Chagas disease; Consensus analysis; Explanatory models; Structural barriers

Mesh:

Year:  2015        PMID: 26432176     DOI: 10.1016/j.socscimed.2015.09.022

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

1.  Chagas Disease Has Not Been Controlled in Ecuador.

Authors:  Eric Dumonteil; Claudia Herrera; Luiggi Martini; Mario J Grijalva; Angel G Guevara; Jaime A Costales; H Marcelo Aguilar; S Frédérique Brenière; Etienne Waleckx
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

2.  "I Cannot Be Worried": Living with Chagas Disease in Tropical Bolivia.

Authors:  Colin J Forsyth
Journal:  PLoS Negl Trop Dis       Date:  2017-01-18

3.  Awareness of Chagas disease and socioeconomic characteristics of Bolivian immigrants living in Sao Paulo, Brazil.

Authors:  Rubens Antonio da Silva; Dalva Marli Valério Wanderley; Colin Forsyth; Ruth Moreira Leite; Expedito José de Albuquerque Luna; Nivaldo Carneiro Júnior; Maria Aparecida Shikanai-Yasuda
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-06-17       Impact factor: 1.846

4.  Leishmaniasis patients' pilgrimage to access health care in rural Bolivia: a qualitative study using human rights to health approach.

Authors:  Daniel Eid; Miguel San Sebastian; Anna-Karin Hurtig; Isabel Goicolea
Journal:  BMC Int Health Hum Rights       Date:  2019-03-05

5.  Cultural perception of triatomine bugs and Chagas disease in Bolivia: a cross-sectional field study.

Authors:  Andrea Salm; Jürg Gertsch
Journal:  Parasit Vectors       Date:  2019-06-10       Impact factor: 3.876

6.  "It's Like a Phantom Disease": Patient Perspectives on Access to Treatment for Chagas Disease in the United States.

Authors:  Colin J Forsyth; Salvador Hernandez; Carmen A Flores; Mario F Roman; J Maribel Nieto; Grecia Marquez; Juan Sequeira; Harry Sequeira; Sheba K Meymandi
Journal:  Am J Trop Med Hyg       Date:  2018-01-25       Impact factor: 2.345

7.  A four-step process for building sustainable access to diagnosis and treatment of Chagas disease.

Authors:  Carolina Batista; Colin J Forsyth; Rafael Herazo; Marina Pereira Certo; Andrea Marchiol
Journal:  Rev Panam Salud Publica       Date:  2019-09-20

8.  Social determinants in the access to health care for Chagas disease: A qualitative research on family life in the "Valle Alto" of Cochabamba, Bolivia.

Authors:  I Jimeno; N Mendoza; F Zapana; L de la Torre; F Torrico; D Lozano; C Billot; M J Pinazo
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.